Debra Friedman
Faculty Member
Last active: 2/12/2015

Genitourinary long-term outcomes for childhood cancer survivors.

Shnorhavorian M, Friedman DL, Koyle MA
Curr Urol Rep. 2009 10 (2): 134-7

PMID: 19239818 · DOI:10.1007/s11934-009-0024-9

The treatment of pediatric malignancies represents one of the success stories of modern medicine. As survival has increased, the focus is now on minimizing harmful effects of treatment. There continue to be late toxicities and secondary malignancies of the genitourinary (GU) system for childhood cancer survivors related to the specific therapeutic exposures. A systematic approach is important for prevention and treatment of these adverse late GU effects.

MeSH Terms (15)

Antineoplastic Agents Carcinoma, Renal Cell Child Disease-Free Survival Dose-Response Relationship, Drug Health Status Humans Kidney Neoplasms Neoplasms, Second Primary Quality of Life Radiotherapy Dosage Survivors Urinary Bladder Neoplasms Urinary Tract Urogenital Neoplasms

Connections (1)

This publication is referenced by other Labnodes entities: